Nuclear Medicine Market Size, Share and Growth Forecast for 2024-2031

Nuclear Medicine Market by Product (Diagnostics, SPECT, PET), by Application (Urology, Cardiology, Neurology), by End Use (Hospitals, Diagnostic Centres), and by Region

Nuclear Medicine Market

Industry: Healthcare

Published Date: August-2024

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 180

Report ID: PMRREP34724

Report Price

$4900*

Buy Now

Table of Content

1. Executive Summary
    1.1. Global Nuclear Medicine Market Snapshot, 2024 and 2031
    1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
    1.3. Key Market Trends
    1.4. Future Market Projections
    1.5. Premium Market Insights
    1.6. Industry Developments and Key Market Events
    1.7. PMR Analysis and Recommendations

2. Market Overview
    2.1. Market Scope and Definition
    2.2. Market Dynamics
        2.2.1. Drivers
        2.2.2. Restraints
        2.2.3. Opportunity
        2.2.4. Challenges
        2.2.5. Key Trends
    2.3. Macro-Economic Factors
        2.3.1. Global Sectorial Outlook
        2.3.2. Global GDP Growth Outlook
        2.3.3. Global Healthcare Spending Outlook
    2.4. COVID-19 Impact Analysis
    2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights
    3.1. Epidemiology - Disease Prevalence and Incidence
    3.2. Technology Assessment
    3.3. Regulatory Landscape
    3.4. Value Chain Analysis
    3.5. Key Deals and Mergers
    3.6. PESTLE Analysis
    3.7. Porter’s Five Force Analysis

4. Global Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
    4.1. Key Highlights
        4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
        4.1.2. Absolute $ Opportunity
    4.2. Market Size (US$ Bn) Analysis and Forecast
        4.2.1. Historical Market Size (US$ Bn) Analysis, 2018-2022
        4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
    4.3. Global Nuclear Medicine Market Outlook: Product
        4.3.1. Introduction / Key Findings
        4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2018 - 2022
        4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
            4.3.3.1. Diagnosis
            4.3.3.2. SPECT
            4.3.3.3. PET
    4.4. Market Attractiveness Analysis: Product
    4.5. Global Nuclear Medicine Market Outlook: Application
        4.5.1. Introduction / Key Findings
        4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2018 - 2022
        4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
            4.5.3.1. Urology
            4.5.3.2. Cardiology
            4.5.3.3. Neurology
    4.6. Market Attractiveness Analysis: Application
    4.7. Global Nuclear Medicine Market Outlook: End Use
        4.7.1. Introduction / Key Findings
        4.7.2. Historical Market Size (US$ Bn) Analysis, By End Use, 2018 - 2022
        4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
            4.7.3.1. Hospitals
            4.7.3.2. Diagnostic Centres
    4.8. Market Attractiveness Analysis: End Use

5. Global Nuclear Medicine Market Outlook: Region
    5.1. Key Highlights
    5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2018 - 2022
    5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2023 - 2031
        5.3.1. North America
        5.3.2. Europe
        5.3.3. East Asia
        5.3.4. South Asia and Oceania
        5.3.5. Latin America
        5.3.6. Middle East & Africa
    5.4. Market Attractiveness Analysis: Region

6. North America Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
    6.1. Key Highlights
    6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
        6.2.1. By Country
        6.2.2. By Product
        6.2.3. By Application
        6.2.4. By End Use
    6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
        6.3.1. U.S.
        6.3.2. Canada
    6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
        6.4.1. Diagnosis
        6.4.2. SPECT
        6.4.3. PET
    6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
        6.5.1. Urology
        6.5.2. Cardiology
        6.5.3. Neurology
    6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
        6.6.1. Hospitals
        6.6.2. Diagnostic Centres
    6.7. Market Attractiveness Analysis

7. Europe Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
    7.1. Key Highlights
    7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
        7.2.1. By Country
        7.2.2. By Product
        7.2.3. By Application
        7.2.4. By End Use
    7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
        7.3.1. Germany
        7.3.2. France
        7.3.3. U.K.
        7.3.4. Italy
        7.3.5. Spain
        7.3.6. Russia
        7.3.7. Türkiye
        7.3.8. Rest of Europe
    7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
        7.4.1. Diagnosis
        7.4.2. SPECT
        7.4.3. PET
    7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
        7.5.1. Urology
        7.5.2. Cardiology
        7.5.3. Neurology
    7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
        7.6.1. Hospitals
        7.6.2. Diagnostic Centres
    7.7. Market Attractiveness Analysis

8. East Asia Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
    8.1. Key Highlights
    8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
        8.2.1. By Country
        8.2.2. By Product
        8.2.3. By Application
        8.2.4. By End Use
    8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
        8.3.1. China
        8.3.2. Japan
        8.3.3. South Korea
    8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
        8.4.1. Diagnosis
        8.4.2. SPECT
        8.4.3. PET
    8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
        8.5.1. Urology
        8.5.2. Cardiology
        8.5.3. Neurology
    8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
        8.6.1. Hospitals
        8.6.2. Diagnostic Centres
    8.7. Market Attractiveness Analysis

9. South Asia & Oceania Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
    9.1. Key Highlights
    9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
        9.2.1. By Country
        9.2.2. By Product
        9.2.3. By Application
        9.2.4. By End Use
    9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
        9.3.1. India
        9.3.2. Southeast Asia
        9.3.3. ANZ
        9.3.4. Rest of South Asia & Oceania
    9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
        9.4.1. Diagnosis
        9.4.2. SPECT
        9.4.3. PET
    9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
        9.5.1. Urology
        9.5.2. Cardiology
        9.5.3. Neurology
    9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
        9.6.1. Hospitals
        9.6.2. Diagnostic Centres
    9.7. Market Attractiveness Analysis

10. Latin America Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
    10.1. Key Highlights
    10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
        10.2.1. By Country
        10.2.2. By Product
        10.2.3. By Application
        10.2.4. By End Use
    10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
        10.3.1. Brazil
        10.3.2. Mexico
        10.3.3. Rest of Latin America
    10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
        10.4.1. Diagnosis
        10.4.2. SPECT
        10.4.3. PET
    10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
        10.5.1. Urology
        10.5.2. Cardiology
        10.5.3. Neurology
    10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
        10.6.1. Hospitals
        10.6.2. Diagnostic Centres
    10.7. Market Attractiveness Analysis

11. Middle East & Africa Nuclear Medicine Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
    11.1. Key Highlights
    11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
        11.2.1. By Country
        11.2.2. By Product
        11.2.3. By Application
        11.2.4. By End Use
    11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
        11.3.1. GCC Countries
        11.3.2. Egypt
        11.3.3. South Africa
        11.3.4. Northern Africa
        11.3.5. Rest of Middle East & Africa
    11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
        11.4.1. Diagnosis
        11.4.2. SPECT
        11.4.3. PET
    11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
        11.5.1. Urology
        11.5.2. Cardiology
        11.5.3. Neurology
    11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
        11.6.1. Hospitals
        11.6.2. Diagnostic Centres
    11.7. Market Attractiveness Analysis

12. Competition Landscape
    12.1. Market Share Analysis, 2023
    12.2. Market Structure
        12.2.1. Competition Intensity Mapping By Market
        12.2.2. Competition Dashboard
    12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
        12.3.1. GE Healthcare
            12.3.1.1. Overview
            12.3.1.2. Segments and Products
            12.3.1.3. Key Financials
            12.3.1.4. Market Developments
            12.3.1.5. Market Strategy
        12.3.2. Jubilant Life Sciences Ltd
        12.3.3. Nordion (Canada), Inc.
        12.3.4. Bracco Imaging S.P.A
        12.3.5. The institute for radioelements (IRE)
        12.3.6. NTP Radioisotopes SOC Ltd.
        12.3.7. The Australian Nuclear Science and Technology Organization
        12.3.8. Eczac?ba??-Monrol
        12.3.9. Lantheus Medical Imaging, Inc
        12.3.10. Eckert & Ziegler
        12.3.11. Mallinckrodt
        12.3.12. Cardinal Health

13. Appendix
    13.1. Research Methodology
    13.2. Research Assumptions
    13.3. Acronyms and Abbreviations

Sample Report

Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

List Of Table

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate